With new opportunities emerging and new, stricter rules and regulations raising the bar even higher, the pharmaceutical landscape is changing radically. Joining these developments is China’s rapidly expanding and diversifying pharmaceutical market, which is set to enter the world’s top five in 2010.

In the midst of all the turmoil, CPhI, ICSE and P-MEC China continue to give the pharmaceutical world a clear and unrivalled insight in new developments and opportunities in the Chinese and international markets.